Neoleukin Therapeutics, Inc. - stock earnings
Stock symbol NLTX is outdated, potentially delisted? Maybe it is available on other exchange?
NLTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -2.1 million USD | ? USD |
| 2023Q1 | -14.2 million USD | ? USD |
| 2022Q4 | -13.4 million USD | ? USD |
| 2022Q3 | -13.1 million USD | ? USD |
| 2022Q2 | -15.7 million USD | ? USD |
| 2022Q1 | -15.4 million USD | ? USD |
| 2021Q4 | -15.2 million USD | ? USD |
| 2021Q3 | -15.4 million USD | ? USD |
| 2021Q2 | -15.1 million USD | ? USD |
| 2021Q1 | -15.0 million USD | ? USD |
| 2020Q4 | -12.6 million USD | ? USD |
NLTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -57.6 million USD | ? USD |
| 2021 | -60.7 million USD | ? USD |
| 2020 | -33.3 million USD | ? USD |
| 2019 | -69.4 million USD | ? USD |
| 2018 | -31.6 million USD | 25.0 million USD |
| 2017 | -50.2 million USD | ? USD |
NLTX
Price: $3.49
52 week price:
Earnings Per Share: -0.17 USD
P/E Ratio: -19.78
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 20300
Market Capitalization: 31.5 million